+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia



Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia



International Journal of Tuberculosis and Lung Disease 13(10): 1309-1312



Joint World Health Organization (WHO) projects in Vladimir and Orel regions, Russia. To study the prevalence of extensively drug-resistant (XDR) tuberculosis (TB). Drug susceptibility testing of second-line drugs (ofloxacin, kanamycin, capreomycin, ethionamide, cycloserine and para-aminosalicylic acid) was performed on isolates from multidrug-resistant TB cases from 1 January to 31 December 2006. In Orel, 16 (21.3%) of 75 tested isolates were XDR-TB; in Vladimir, 9 (4.9%) of 182 isolates were XDR-TB. Bilateral lung involvement was significantly associated with XDR-TB (prevalence ratio = 2.61, 95%CI 1.01-6.72). XDR-TB has emerged in Russia. It is crucial to prevent, diagnose and treat TB and MDR-TB more effectively.

(PDF emailed within 1 workday: $29.90)

Accession: 055157711

Download citation: RISBibTeXText

PMID: 19793439


Related references

Performance of Cepheid ® Xpert MTB/RIF ® and TB-Biochip ® MDR in two regions of Russia with a high prevalence of drug-resistant tuberculosis. European Journal of Clinical Microbiology & Infectious Diseases 32(6): 735-743, 2013

Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin). Journal of the College of Physicians and Surgeons--Pakistan 25(5): 337-341, 2016

Microevolution of extensively drug-resistant tuberculosis in Russia. Genome Research 22(4): 735-745, 2012

Prevalence of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: a retrospective hospital-based study. Indian Journal of Medical Research 130(4): 392-395, 2010

Prevalence of multidrug-resistant and extensively drug-resistant tuberculosis in patients with pulmonary tuberculosis in zahedan, southeastern iran. Iranian Red Crescent Medical Journal 14(1): 53-55, 2012

The emergence of extensively drug-resistant tuberculosis (TB): TB/HIV coinfection, multidrug-resistant TB and the resulting public health threat from extensively drug-resistant TB, globally and in Canada. Canadian Journal of Infectious Diseases & Medical Microbiology 18(5): 289-291, 2008

Prevalence of Extensively Drug Resistant Tuberculosis among Archived Multidrug Resistant Tuberculosis Isolates in Zimbabwe. Tuberculosis Research and Treatment 2014: 349141-349141, 2014

Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in Rural China. Antimicrobial Agents and ChemoTherapy 57(8): 3857-3863, 2014

Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 372(9647): 1403-1409, 2008

Susceptibility testing of extensively drug-resistant and pre-extensively drug-resistant Mycobacterium tuberculosis against levofloxacin, linezolid, and amoxicillin-clavulanate. Antimicrobial Agents and ChemoTherapy 57(6): 2522-2525, 2013

Prevalence of extensively drug-resistant tuberculosis. European Respiratory Journal 34(3): 780; Author Reply 780-1, 2010

Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting. International Journal of Tuberculosis and Lung Disease 15(9): 1170-5, i, 2012

Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. Plos One 5(12): E15735-E15735, 2011

Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease. Mikrobiyoloji Bulteni 45(1): 181-195, 2011

Extensively drug-resistant tuberculosis: New Zealand's first case and the challenges of management in a low-prevalence country. Medical Journal of Australia 194(11): 602-604, 2011